Autoimmunity Across Systems: Thyroid, Skin, Joint and Gut Overlaps

A woman with Hashimoto thyroiditis develops fatigue and iron deficiency and is found to have coeliac disease. A man with psoriasis develops joint pain and later diarrhoea, and is diagnosed with psoriatic arthritis and then Crohn disease. A young adult with type 1 diabetes develops hypothyroidism. These are not coincidences. Autoimmune diseases cluster, and understanding the patterns helps practitioners anticipate, screen for and coordinate the care of conditions that cross traditional specialty boundaries.

Why autoimmune diseases cluster

• Shared genes. Variants in the HLA region and in immune regulatory genes such as PTPN22 increase susceptibility to several autoimmune diseases.
• Shared immune pathways. Some conditions share specific inflammatory pathways; the interleukin 23 and interleukin 17 axis, for example, is central to psoriasis, psoriatic arthritis and some forms of spondyloarthritis.
• Shared environmental triggers, such as smoking, infections and hormonal changes.
• Female predominance in many conditions.
• Epitope spreading, in which an established autoimmune response broadens to new targets over time.

Having one autoimmune disease is associated with a higher risk of developing another, and polyautoimmunity, the presence of more than one, is common.

Recognised clusters

The gut across autoimmune disease

The gut features in many clusters. Coeliac disease is more common in autoimmune thyroid disease and type 1 diabetes. Inflammatory bowel disease overlaps with psoriasis and spondyloarthritis. Autoimmune gastritis causes B12 and iron deficiency. Microscopic colitis is associated with several autoimmune conditions. New or persistent gut symptoms in a person with any autoimmune disease should prompt consideration of these associations rather than being attributed to stress or diet alone.

Treatment choices that span conditions

Because autoimmune conditions share pathways, treatments can affect several at once, for better or worse.

• Some biologic medicines treat psoriasis, psoriatic arthritis and inflammatory bowel disease together.
• Interleukin 17 inhibitors, effective for psoriasis, can worsen or trigger inflammatory bowel disease in some people, so a history of bowel symptoms influences choice.
• Anti TNF medicines occasionally cause paradoxical psoriasis.
• Immune checkpoint inhibitors used in cancer can trigger multiple autoimmune conditions.
• Glucocorticoids affect glucose, bone, mood and infection risk across conditions.

Coordination between specialists, and awareness of the whole autoimmune picture, supports better treatment decisions.

Screening sensibly

Targeted screening is guided by established associations and by symptoms, not by broad antibody panels in people without symptoms, which can produce positive results of uncertain meaning. Reasonable approaches include:

• coeliac serology in type 1 diabetes, autoimmune thyroid disease with gut symptoms or iron deficiency, and unexplained iron deficiency;
• thyroid function in type 1 diabetes, coeliac disease and other autoimmune conditions, periodically or with symptoms;
• B12 in autoimmune thyroid disease and vitiligo with symptoms;
• assessment for inflammatory arthritis in psoriasis using screening questions;
• bowel assessment with calprotectin in spondyloarthritis or psoriasis with persistent bowel symptoms;
• consideration of Addison disease in people with endocrine autoimmunity and suggestive features.

Supporting patients with more than one condition

1. Maintain an overview of all conditions, specialists and treatments.
2. Coordinate with each specialist, sharing relevant information.
3. Address shared mediators: smoking, weight, sleep, stress, physical activity, diet quality.
4. Monitor nutritional status, which may be affected by multiple conditions and treatments.
5. Interpret new symptoms in the light of known associations.
6. Support mental health, given the burden of multiple chronic conditions.

An illustrative case

A 36 year old woman with Hashimoto thyroiditis on levothyroxine and vitiligo presents with fatigue and loose stools. Her TSH has become unstable despite consistent dosing. Her ferritin and B12 are low. Recognising the autoimmune cluster, her practitioner and doctor check coeliac serology, which is positive; biopsy confirms coeliac disease. Intrinsic factor antibodies are also positive, indicating autoimmune gastritis. She starts a gluten free diet with a dietitian and B12 replacement, her iron is corrected, and her levothyroxine dose is adjusted as absorption improves. Her doctor notes her increased risk of other endocrine autoimmunity and arranges periodic review. 6 months later her energy and bowel habit have improved and her TSH is stable.

Thinking across boundaries

Autoimmune diseases do not respect specialty boundaries. Recognising the clusters in which they occur allows practitioners to anticipate associated conditions, screen appropriately, interpret new symptoms accurately and coordinate treatment choices, turning a fragmented set of diagnoses into a coherent picture of one person’s immune health.